Scientists have developed an artificial pancreas system integrated with smartphones to continuously monitor glucose levels of diabetics and automatically deliver required doses of insulin.

During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week clinical trial showed significant improvements in two key measures of well-being in people living with type 1 diabetes.

Thirty patients with type 1 diabetes went about their normal daily routines while the artificial pancreas system continuously monitored their glucose levels and automatically adapted insulin delivery settings.

The results, published in the journal Diabetes Care, revealed positive effects on two important indicators: decreased hemoglobin A1c (HbA1c) and reduced time spent in hypoglycemia.

The trial was led by Frank Doyle and Eyal Dassau from the Harvard John A Paulson School of Engineering and Applied Sciences (SEAS).....Read more

Source web page:New Indian Express